312 related articles for article (PubMed ID: 26960975)
1. The Error-Prone DNA Polymerase κ Promotes Temozolomide Resistance in Glioblastoma through Rad17-Dependent Activation of ATR-Chk1 Signaling.
Peng C; Chen Z; Wang S; Wang HW; Qiu W; Zhao L; Xu R; Luo H; Chen Y; Chen D; You Y; Liu N; Wang H
Cancer Res; 2016 Apr; 76(8):2340-53. PubMed ID: 26960975
[TBL] [Abstract][Full Text] [Related]
2. BACH1 Promotes Temozolomide Resistance in Glioblastoma through Antagonizing the Function of p53.
Nie E; Jin X; Wu W; Yu T; Zhou X; Zhi T; Shi Z; Zhang J; Liu N; You Y
Sci Rep; 2016 Dec; 6():39743. PubMed ID: 28000777
[TBL] [Abstract][Full Text] [Related]
3. Augmented HR Repair Mediates Acquired Temozolomide Resistance in Glioblastoma.
Gil Del Alcazar CR; Todorova PK; Habib AA; Mukherjee B; Burma S
Mol Cancer Res; 2016 Oct; 14(10):928-940. PubMed ID: 27358111
[TBL] [Abstract][Full Text] [Related]
4. Contribution of ATM and ATR to the resistance of glioblastoma and malignant melanoma cells to the methylating anticancer drug temozolomide.
Eich M; Roos WP; Nikolova T; Kaina B
Mol Cancer Ther; 2013 Nov; 12(11):2529-40. PubMed ID: 23960094
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of GSH synthesis potentiates temozolomide-induced bystander effect in glioblastoma.
Kohsaka S; Takahashi K; Wang L; Tanino M; Kimura T; Nishihara H; Tanaka S
Cancer Lett; 2013 Apr; 331(1):68-75. PubMed ID: 23246370
[TBL] [Abstract][Full Text] [Related]
6. ATM inhibitor KU-55933 increases the TMZ responsiveness of only inherently TMZ sensitive GBM cells.
Nadkarni A; Shrivastav M; Mladek AC; Schwingler PM; Grogan PT; Chen J; Sarkaria JN
J Neurooncol; 2012 Dec; 110(3):349-57. PubMed ID: 23054561
[TBL] [Abstract][Full Text] [Related]
7. Estrogen receptor beta enhances chemotherapy response of GBM cells by down regulating DNA damage response pathways.
Zhou M; Sareddy GR; Li M; Liu J; Luo Y; Venkata PP; Viswanadhapalli S; Tekmal RR; Brenner A; Vadlamudi RK
Sci Rep; 2019 Apr; 9(1):6124. PubMed ID: 30992459
[TBL] [Abstract][Full Text] [Related]
8. MALAT1 is a prognostic factor in glioblastoma multiforme and induces chemoresistance to temozolomide through suppressing miR-203 and promoting thymidylate synthase expression.
Chen W; Xu XK; Li JL; Kong KK; Li H; Chen C; He J; Wang F; Li P; Ge XS; Li FC
Oncotarget; 2017 Apr; 8(14):22783-22799. PubMed ID: 28187000
[TBL] [Abstract][Full Text] [Related]
9. Nuclear factor I A promotes temozolomide resistance in glioblastoma via activation of nuclear factor κB pathway.
Yu X; Wang M; Zuo J; Wahafu A; Mao P; Li R; Wu W; Xie W; Wang J
Life Sci; 2019 Nov; 236():116917. PubMed ID: 31614149
[TBL] [Abstract][Full Text] [Related]
10. Investigating a signature of temozolomide resistance in GBM cell lines using metabolomics.
St-Coeur PD; Poitras JJ; Cuperlovic-Culf M; Touaibia M; Morin P
J Neurooncol; 2015 Oct; 125(1):91-102. PubMed ID: 26311249
[TBL] [Abstract][Full Text] [Related]
11. TAZ promotes temozolomide resistance by upregulating MCL-1 in human glioma cells.
Tian T; Li A; Lu H; Luo R; Zhang M; Li Z
Biochem Biophys Res Commun; 2015 Aug; 463(4):638-43. PubMed ID: 26043698
[TBL] [Abstract][Full Text] [Related]
12. Minor Changes in Expression of the Mismatch Repair Protein MSH2 Exert a Major Impact on Glioblastoma Response to Temozolomide.
McFaline-Figueroa JL; Braun CJ; Stanciu M; Nagel ZD; Mazzucato P; Sangaraju D; Cerniauskas E; Barford K; Vargas A; Chen Y; Tretyakova N; Lees JA; Hemann MT; White FM; Samson LD
Cancer Res; 2015 Aug; 75(15):3127-38. PubMed ID: 26025730
[TBL] [Abstract][Full Text] [Related]
13. Temozolomide Induces Senescence and Repression of DNA Repair Pathways in Glioblastoma Cells via Activation of ATR-CHK1, p21, and NF-κB.
Aasland D; Götzinger L; Hauck L; Berte N; Meyer J; Effenberger M; Schneider S; Reuber EE; Roos WP; Tomicic MT; Kaina B; Christmann M
Cancer Res; 2019 Jan; 79(1):99-113. PubMed ID: 30361254
[TBL] [Abstract][Full Text] [Related]
14. Hyperoxia resensitizes chemoresistant glioblastoma cells to temozolomide through unfolded protein response.
Lee D; Sun S; Ho AS; Kiang KM; Zhang XQ; Xu FF; Leung GK
Anticancer Res; 2014 Jun; 34(6):2957-66. PubMed ID: 24922660
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-132 induces temozolomide resistance and promotes the formation of cancer stem cell phenotypes by targeting tumor suppressor candidate 3 in glioblastoma.
Cheng ZX; Yin WB; Wang ZY
Int J Mol Med; 2017 Nov; 40(5):1307-1314. PubMed ID: 28901390
[TBL] [Abstract][Full Text] [Related]
16. c-Myc-miR-29c-REV3L signalling pathway drives the acquisition of temozolomide resistance in glioblastoma.
Luo H; Chen Z; Wang S; Zhang R; Qiu W; Zhao L; Peng C; Xu R; Chen W; Wang HW; Chen Y; Yang J; Zhang X; Zhang S; Chen D; Wu W; Zhao C; Cheng G; Jiang T; Lu D; You Y; Liu N; Wang H
Brain; 2015 Dec; 138(Pt 12):3654-72. PubMed ID: 26450587
[TBL] [Abstract][Full Text] [Related]
17. Role of miR-223/paired box 6 signaling in temozolomide chemoresistance in glioblastoma multiforme cells.
Cheng Q; Ma X; Cao H; Chen Z; Wan X; Chen R; Peng R; Huang J; Jiang B
Mol Med Rep; 2017 Feb; 15(2):597-604. PubMed ID: 28035389
[TBL] [Abstract][Full Text] [Related]
18. The DNA repair protein ALKBH2 mediates temozolomide resistance in human glioblastoma cells.
Johannessen TC; Prestegarden L; Grudic A; Hegi ME; Tysnes BB; Bjerkvig R
Neuro Oncol; 2013 Mar; 15(3):269-78. PubMed ID: 23258843
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of novel imidazotetrazine analogues designed to overcome temozolomide resistance and glioblastoma regrowth.
Ramirez YP; Mladek AC; Phillips RM; Gynther M; Rautio J; Ross AH; Wheelhouse RT; Sakaria JN
Mol Cancer Ther; 2015 Jan; 14(1):111-9. PubMed ID: 25351918
[TBL] [Abstract][Full Text] [Related]
20. Temozolomide resistance in glioblastoma occurs by miRNA-9-targeted PTCH1, independent of sonic hedgehog level.
Munoz JL; Rodriguez-Cruz V; Ramkissoon SH; Ligon KL; Greco SJ; Rameshwar P
Oncotarget; 2015 Jan; 6(2):1190-201. PubMed ID: 25595896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]